President Donald Trump’s first Food and Drug Administration head (FDA) Scott Gottlieb, has released a very detailed plan on how reopen the American economy. The plan involves a truly massive expansion of the public healthcare system — to the tune of hiring thousands of new workers — and ramping up testing to well over 3 million tests per week.
Today we published a detailed blueprint for how the U.S. can build a robust surveillance and case-based system to reduce the risk of future #COVID19 outbreaks. We outline the elements of effective surveillance, testing, and track and trace interventions https://t.co/eTgrKer7ga
- “Establishing test and trace infrastructure:” Also described as the “capacity for widespread diagnostic testing and data sharing to enable rapid case-based interventions.”
- “Syndromic surveillance: Integration of test and trace into an enhanced national syndromic
- “Serologic testing: capacity to conduct widespread serologic testing to identify reliable
markers of immunity.”
- “Rapid response: capacity for isolation, contact tracing, and quarantine”